Literature DB >> 8380589

Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors.

T Doi1, K Higashino, Y Kurihara, Y Wada, T Miyazaki, H Nakamura, S Uesugi, T Imanishi, Y Kawabe, H Itakura.   

Abstract

Macrophage scavenger receptors mediate the recognition of a wide range of negatively charged macromolecules including modified low density lipoproteins (LDL). Truncated bovine receptors lacking residues 330-342, which include the conserved lysine cluster of a collagen-like domain, were unable to degrade modified LDL in spite of their expression on the cell surface. Substitution of lysine 337 into alanine abolished the acetyl-LDL degradation and binding at 37 degrees C, but did not abolish the 4 degrees C binding. In contrast, substitution of more than 2 lysines in this region are needed to abolish the oxidized LDL degradation and 37 degrees C binding. Based on computational modeling of this domain, we propose that a "charged collagen" structure containing a lysine cluster forms a positively charged groove which specifically interacts with negatively charged ligands.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380589

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding.

Authors:  M Chen; S Narumiya; T Masaki; T Sawamura
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

Review 2.  Unstable molecules form stable tissues.

Authors:  Anton V Persikov; Barbara Brodsky
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

Review 3.  Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale.

Authors:  N Platt; S Gordon
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

4.  The class A macrophage scavenger receptor type I (SR-AI) recognizes complement iC3b and mediates NF-κB activation.

Authors:  Jason W K Goh; Yen Seah Tan; Alister W Dodds; Kenneth B M Reid; Jinhua Lu
Journal:  Protein Cell       Date:  2010-02-06       Impact factor: 14.870

5.  Multimodality PET/MRI agents targeted to activated macrophages.

Authors:  Chuqiao Tu; Thomas S C Ng; Russell E Jacobs; Angelique Y Louie
Journal:  J Biol Inorg Chem       Date:  2013-10-29       Impact factor: 3.358

6.  Feraheme (Ferumoxytol) Is Recognized by Proinflammatory and Anti-inflammatory Macrophages via Scavenger Receptor Type AI/II.

Authors:  Guankui Wang; Natalie J Serkova; Ernest V Groman; Robert I Scheinman; Dmitri Simberg
Journal:  Mol Pharm       Date:  2019-09-26       Impact factor: 4.939

7.  Class A scavenger receptor expression and function in eight novel tadpole cell lines from the green frog (Lithobates clamitans) and the wood frog (Lithobates sylvatica).

Authors:  Nguyen T K Vo; Joshua Everson; Levi Moore; Stephanie J DeWitte-Orr
Journal:  Cytotechnology       Date:  2019-06-06       Impact factor: 2.058

8.  The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome.

Authors:  Jorge Vera; Rafael Fenutría; Olga Cañadas; Maite Figueras; Rubén Mota; Maria-Rosa Sarrias; David L Williams; Cristina Casals; José Yelamos; Francisco Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-13       Impact factor: 11.205

9.  Modified low density lipoproteins binding requires a lysine cluster region in the murine macrophage scavenger receptor class A type II.

Authors:  Francisco J Leyva; Mark A Pershouse; Andrij Holian
Journal:  Mol Biol Rep       Date:  2009-09-23       Impact factor: 2.316

10.  Macrophage scavenger receptor A mediates adhesion to apolipoproteins A-I and E.

Authors:  Claudine Neyen; Annette Plüddemann; Pietro Roversi; Benjamin Thomas; Lei Cai; Deneys R van der Westhuyzen; Robert B Sim; Siamon Gordon
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.